Vascular actions of 20-HETE

Prostaglandins and Other Lipid Mediators

Volumn 120, Issue , 2015, Pages 9-16

  Hoopes, Samantha L ^a   Garcia, Victor ^b   Edin, Matthew L ^a   Schwartzman, Michal L ^b   Zeldin, Darryl C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

20 HETE; Angiogenesis; Renin angiotensin system; Vascular dysfunction; Vascular inflammation; Vascular remodeling

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; HYDROXYICOSATETRAENOIC ACID;

ANGIOGENESIS; ARTICLE; BIOSYNTHESIS; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR REMODELING; VASCULITIS; VASOCONSTRICTION; ANIMAL; BLOOD VESSEL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD VESSELS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; NEOVASCULARIZATION, PHYSIOLOGIC; RENIN-ANGIOTENSIN SYSTEM; VASCULAR DISEASES; VASCULAR REMODELING;

EID: 84941802802     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.03.002     Document Type: Review

References (117)

1. V.B. O'Donnell, B. Maskrey, and G.W. Taylor Eicosanoids: generation and detection in mammalian cells Methods Mol Biol 462 2009 5 23
2. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 1 2002 131 185
3. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase J Lipid Res 41 2 2000 163 181
4. P.K. Powell, I. Wolf, R. Jin, and J.M. Lasker Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11 J Pharmacol Exp Ther 285 3 1998 1327 1336
5. J.M. Lasker, W.B. Chen, I. Wolf, and et al. Formation of 20-hydroxyeicosatetraenoic acid: a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11 J Biol Chem 275 6 2000 4118 4126
6. D.N. Muller, C. Schmidt, E. Barbosa-Sicard, and et al. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation Biochem J 403 1 2007 109 118
7. K. Nakagawa, V.R. Holla, Y. Wei, and et al. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel J Clin Invest 116 6 2006 1696 1702
8. S. Kimura, N. Hanioka, E. Matsunaga, and F.J. Gonzalez The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes: unique exon organization, and identification of a conserved 19-bp upstream element DNA 8 7 1989 503 516
9. S. Kimura, J.P. Hardwick, C.A. Kozak, and F.J. Gonzalez The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3: mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes DNA 8 7 1989 517 525
10. M. Stromstedt, S. Hayashi, P.G. Zaphiropoulos, and J.A. Gustafsson Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate DNA Cell Biol 9 8 1990 569 577
11. C.L. Lino Cardenas, A. Devos, A. Toure, and et al. Arachidonic acid omega-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant Mol Biol Rep 39 2 2012 1503 1508
12. D.E. Stec, R.J. Roman, A. Flasch, and M.J. Rieder Functional polymorphism in human CYP4F2 decreases 20-HETE production Physiol Genomics 30 1 2007 74 81
13. N.C. Ward, I.J. Tsai, A. Barden, and et al. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure Hypertension 51 5 2008 1393 1398
14. D. Gebremedhin, A.R. Lange, J. Narayanan, and et al. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current J Physiol 507 1998 771 781
15. J.M. Williams, S. Murphy, M. Burke, and R.J. Roman 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension J Cardiovasc Pharmacol 56 4 2010 336 344
16. F. Xu, J.R. Falck, P.R. Ortiz de Montellano, and D.L. Kroetz Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes J Pharmacol Exp Ther 308 3 2004 887 895
17. H. Singh, J. Cheng, H. Deng, and et al. Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension Hypertension 50 1 2007 123 129
18. N. Miyata, and R.J. Roman Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system J Smooth Muscle Res 41 4 2005 175 193
19. D.R. Harder, D. Gebremedhin, J. Narayanan, and et al. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels Am J Physiol 266 5 Pt 2 1994 H2098 H2107
20. J.H. Parmentier, E.N. Lavrentyev, J.R. Falck, J.H. Capdevila, and K.U. Malik Evaluation of cytochrome P450 4 family as mediator of phospholipase D activation in aortic vascular smooth muscle cells Life Sci 77 9 2005 1015 1029
21. P. Christmas, J.P. Jones, C.J. Patten, and et al. Alternative splicing determines the function of CYP4F3 by switching substrate specificity J Biol Chem 276 41 2001 38166 38172
22. E. Hill, and R.C. Murphy Quantitation of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) produced by human polymorphonuclear leukocytes using electron capture ionization gas chromatography/mass spectrometry Biol Mass Spectrom 21 1992 249 253
23. M. Rosolowsky, J.R. Falck, and W.B. Campbell Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites Biochim Biophys Acta 1300 2 1996 143 150
24. I.J. Tsai, K.D. Croft, I.B. Puddey, L.J. Beilin, and A. Barden 20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1 Am J Physiol Heart Circ Physiol 300 4 2011 H1194 H1200
25. C.C. Wu, and M.L. Schwartzman The role of 20-HETE in androgen-mediated hypertension Prostaglandins Other Lipid Mediat 96 1-4 2011 45 53
26. L. Chen, R. Ackerman, M. Saleh, and et al. 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo J Pharmacol Exp Ther 348 3 2014 442 451
27. J. Cheng, C.C. Wu, K.H. Gotlinger, and et al. 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling J Pharmacol Exp Ther 332 1 2010 57 65
28. T.H. Le, and T.M. Coffman Targeting genes in the renin-angiotensin system Curr Opin Nephrol Hypertens 17 1 2008 57 63
29. B. Cvetkovic, and C.D. Sigmund Understanding hypertension through genetic manipulation in mice Kidney Int 57 3 2000 863 874
30. H.C. Hercule, and A.O. Oyekan Cytochrome P450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole J Pharmacol Exp Ther 292 2000 1153 1160
31. A. Oyekan, M. Balazy, and J.C. McGiff Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II Am J Physiol 273 1 Pt 2 1997 R293 R300
32. A.O. Oyekan, and J.C. McGiff Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat Am J Physiol 274 1 Pt 2 1998 R52 R61
33. J.D. Imig, A.P. Zou, D.E. Stec, and et al. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles Am J Physiol 270 1 Pt 2 1996 R217 R227
34. M.A. Carroll, M. Balazy, P. Margiotta, and et al. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides Am J Physiol 271 4 Pt 2 1996 R863 R869
35. M.A. Carroll, M. Balazy, D.D. Huang, and et al. Cytochrome P450-derived renal HETEs: storage and release Kidney Int 51 1997 1696 1702
36. K.D. Croft, J.C. McGiff, A. Sanchez-Mendoza, and M.A. Carroll Angiotensin II releases 20-HETE from rat renal microvessels Am J Physiol Renal Physiol 279 2000 F544 F551
37. M. Alonso-Galicia, K.G. Maier, A.S. Greene, A.W. Cowley Jr., and R.J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regul Integr Comp Physiol 283 1 2002 R60 R68
38. S.L. Amaral, K.G. Maier, D.N. Schippers, R.J. Roman, and A.S. Greene CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis Am J Physiol Heart Circ Physiol 284 5 2003 H1528 H1535
39. M. Jiang, A. Mezentsev, R. Kemp, and et al. Smooth muscle - specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels Circ Res 94 2 2004 167 174
40. M.M. Muthalif, I.F. Benter, N. Karzoun, and et al. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells Proc Natl Acad Sci U S A 95 21 1998 12701 12706
41. V. Randriamboavonjy, R. Busse, and I. Fleming 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase Hypertension 41 2003 801 806
42. M. Alonso-Galicia, K.G. Maier, A.S. Greene, A.W. Cowley Jr, and R.J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regul Integr Comp Physiol 283 2002 R60 R68
43. V.C. Chabova, H.J. Kramer, I. Vaneckova, and et al. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats Vascul Pharmacol 47 2-3 2007 145 159
44. A.M. Guo, A.S. Arbab, J.R. Falck, and et al. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation J Pharmacol Exp Ther 321 1 2007 18 27
45. A.M. Guo, G. Scicli, J. Sheng, and et al. 20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells Am J Physiol Heart Circ Physiol 297 2 2009 H602 H613
46. X.C. Huang, E.M. Richards, and C. Sumners Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors J Biol Chem 271 26 1996 15635 15641
47. N. Ishizaka, H. De Leon, J.B. Laursen, and et al. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta Circulation 96 1994 1923 1929
48. U. Landmesser, and H. Drexler Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide J Hypertens Suppl 24 1 2006 S39 S43
49. H. Mollnau, M. Wendt, K. Szocs, and et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling Circ Res 90 4 2002 E58 E65
50. R. Morgan-Boyd, J.M. Stewart, R.J. Vavrek, and A. Hassid Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells Am J Physiol 253 1987 C588 C598
51. G. Wolf, and E.G. Neilson Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells Kidney Int Suppl 39 1993 S100 S107
52. T. Ishizuka, J. Cheng, H. Singh, and et al. 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells J Pharmacol Exp Ther 324 1 2008 103 110
53. K. Sodhi, C.C. Wu, J. Cheng, and et al. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent Hypertension 56 2010 871 878
54. J. Cheng, V. Garcia, Y. Ding, and et al. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction Arterioscler Thromb Vasc Biol 32 8 2012 1917 1924
55. D. Sacerdoti, B. Escalante, N.G. Abraham, and et al. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats Science 243 4889 1989 388 390
56. K.M. Dunn, M. Renic, A.K. Flasch, and et al. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol 295 6 2008 H2455 H2465
57. V.R. Holla, F. Adas, J.D. Imig, and et al. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension Proc Natl Acad Sci U S A 98 9 2001 5211 5216
58. C.C. Wu, J. Cheng, F.F. Zhang, and et al. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase Hypertension 57 4 2011 788 794
59. T. Ishizuka, O. Ito, K. Omata, and S. Ito Role of androgens in the renal production of 20-hydroxyeicosatetraenoic acid in spontaneously hypertensive rats Nihon Jinzo Gakkai Shi 46 7 2004 685 692
60. K. Inoue, K. Sodhi, N. Puri, and et al. Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE Am J Physiol Renal Physiol 297 4 2009 F875 F884
61. J.D. Imig 20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension Hypertension 56 5 2010 822 823
62. F. Zhang, M.H. Wang, J.S. Wang, and et al. Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli Am J Physiol Heart Circ Physiol 287 3 2004 H1089 H1095
63. F. Zhang, M.H. Wang, U.M. Krishna, and et al. Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats Hypertension 38 6 2001 1311 1315
64. A.P. Zou, J.T. Fleming, J.R. Falck, and et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated K+ channel in renal arterioles Am J Physiol 270 1996 R228 R237
65. J.C. Frisbee, J.R. Falck, and J.H. Lombard Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension Am J Physiol Heart Circ Physiol 278 2000 H1517 H1526
66. J.S. Wang, H. Singh, F. Zhang, and et al. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus Circ Res 98 7 2006 962 969
67. E. Joly, R. Seqqat, B. Flamion, and et al. Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE Am J Physiol Regul Integr Comp Physiol 291 4 2006 R977 R986
68. E. Schulz, T. Jansen, P. Wenzel, A. Daiber, and T. Munzel Nitric oxide: tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension Antioxid Redox Signal 10 6 2008 1115 1126
69. L.J. Ignarro Biosynthesis and metabolism of endothelium-derived nitric oxide Annu Rev Pharmacol Toxicol 30 1990 535 560
70. H. Cai, and D.G. Harrison Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ Res 87 10 2000 840 844
71. D.G. Harrison Cellular and molecular mechanisms of endothelial cell dysfunction J Clin Invest 100 9 1997 2153 2157
72. J.C. Frisbee, J.R. Falck, and J.H. Lombard Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension Am J Physiol Heart Circ Physiol 278 5 2000 H1517 H1526
73. R.N. Schuck, K.N. Theken, M.L. Edin, and et al. Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients Atherosclerosis 227 2 2013 442 448
74. N.C. Ward, J. Rivera, J. Hodgson, and et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans Circulation 110 4 2004 438 443
75. N.C. Ward, I.B. Puddey, J.M. Hodgson, L.J. Beilin, and K.D. Croft Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects Free Radic Biol Med 38 8 2005 1032 1036
76. J. Cheng, J.S. Ou, H. Singh, and et al. 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling Am J Physiol Heart Circ Physiol 294 2 2008 H1018 H1026
77. E.R. Jacobs, D. Zhu, S. Gruenloh, B. Lopez, and M. Medhora VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase Am J Physiol Lung Cell Mol Physiol 291 3 2006 L369 L377
78. R. Maranon, and J.F. Reckelhoff Sex and gender differences in control of blood pressure Clin Sci (Lond) 125 7 2013 311 318
79. V.R. Holla, F. Adas, J.D. Imig, and et al. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension Proc Natl Acad Sci U S A 98 2001 5211 5216
80. Y. Ding, C.C. Wu, V. Garcia, and et al. 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension Am J Physiol Renal Physiol 305 5 2013 F753 F763
81. C. Zhang The role of inflammatory cytokines in endothelial dysfunction Basic Res Cardiol 103 5 2008 398 406
82. J. Cheng, M.L. Edin, S.L. Hoopes, and et al. Vascular characterization of mice with endothelial expression of cytochrome P450 4F2 FASEB J 28 7 2014 2915 2931
83. C.A. Lemarie, P.L. Tharaux, and S. Lehoux Extracellular matrix alterations in hypertensive vascular remodeling J Mol Cell Cardiol 48 3 2010 433 439
84. H.D. Intengan, and E.L. Schiffrin Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis Hypertension 38 3 Pt 2 2001 581 587
85. A. Ooshima, G.C. Fuller, G.J. Cardinale, S. Spector, and S. Udenfriend Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents Proc Natl Acad Sci U S A 71 8 1974 3019 3023
86. S. Udenfriend, A. Ooshima, G. Cardinale, G.C. Fuller, and S. Spector Increased formation of collagen in the blood vessels of hypertensive rats Ann N Y Acad Sci 275 1976 101 103
87. S. Spector, A. Ooshima, K. Iwatsuki, and et al. Increased vascular collagen biosynthesis by hypertension and reversal by antihypertensive drugs Blood Vessels 15 1-3 1978 176 182
88. A. Ooshima Collagen metabolism in blood vessels of hypertensive rats Jpn Circ J 41 8 1977 912 914
89. A. Ooshima, G. Fuller, G. Cardinale, S. Spector, and S. Udenfriend Collagen biosynthesis in blood vessels of brain and other tissues of the hypertensive rat Science 190 4217 1975 898 900
90. C. Marchesi, P. Paradis, and E.L. Schiffrin Role of the renin-angiotensin system in vascular inflammation Trends Pharmacol Sci 29 7 2008 367 374
91. C.C. Wu, S. Mei, J. Cheng, and et al. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE Synthase J Am Soc Nephrol 2013
92. Y. Issan, E. Hochhauser, A. Guo, and et al. Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia Prostaglandins Other Lipid Mediat 100-101 2013 15 21
93. X. Li, G. Zhao, B. Ma, and et al. 20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616 PLOS ONE 9 4 2014 e95841
94. S. Eid, R. Maalouf, A.A. Jaffa, and et al. 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway PLoS ONE 8 8 2013 e70029
95. S. Eid, W. Abou-Kheir, R. Sabra, and et al. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy J Biol Regul Homeost Agents 27 3 2013 693 703
96. M.H. Gangadhariah, J.M. Luther, V. Garcia, and et al. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy J Am Soc Nephrol 2014
97. U. Hoff, I. Lukitsch, L. Chaykovska, and et al. Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury Kidney Int 79 1 2011 57 65
98. Y. Liu, D. Wang, H. Wang, and et al. The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion Brain Res 1544 2014 45 53
99. L.D. Orozco, H. Liu, E. Perkins, and et al. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries J Pharmacol Exp Ther 346 1 2013 67 74
100. P. Toth, A. Csiszar, D. Sosnowska, and et al. Treatment with the cytochrome P450 omega-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation: oxidative stress and improves vasomotor function in spontaneously hypertensive rats Br J Pharmacol 168 8 2013 1878 1888
101. P. Carmeliet, and R.K. Jain Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases Nat Rev Drug Discov 10 6 2011 417 427
102. W. Risau Mechanisms of angiogenesis Nature 386 6626 1997 671 674
103. H. Gerhardt, M. Golding, M. Fruttiger, and et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 6 2003 1163 1177
104. M. Hellstrom, L.K. Phng, J.J. Hofmann, and et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis Nature 445 7129 2007 776 780
105. A.F. Siekmann, and N.D. Lawson Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries Nature 445 7129 2007 781 784
106. C.Y. Lee, and V.L. Bautch Ups and downs of guided vessel sprouting: the role of polarity Physiology (Bethesda) 26 5 2011 326 333
107. C.O. Lizama, and A.C. Zovein Polarizing pathways: balancing endothelial polarity, permeability, and lumen formation Exp Cell Res 319 9 2013 1247 1254
108. R. Horvat, A. Hovorka, G. Dekan, H. Poczewski, and D. Kerjaschki Endothelial cell membranes contain podocalyxin - the major sialoprotein of visceral glomerular epithelial cells J Cell Biol 102 2 1986 484 491
109. M.L. Iruela-Arispe, and G.E. Davis Cellular and molecular mechanisms of vascular lumen formation Dev Cell 16 2 2009 222 231
110. B. Strilic, T. Kucera, J. Eglinger, and et al. The molecular basis of vascular lumen formation in the developing mouse aorta Dev Cell 17 4 2009 505 515
111. P. Chen, M. Guo, D. Wygle, and et al. Inhibitors of cytochrome P450 4A suppress angiogenic responses Am J Pathol 166 2 2005 615 624
112. L. Chen, R. Ackerman, and A.M. Guo 20-HETE in neovascularization Prostaglandins Other Lipid Mediat 98 3-4 2012 63 68
113. A. Dhanasekaran, S. Bodiga, S. Gruenloh, and et al. 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells Am J Physiol Heart Circ Physiol 296 3 2009 H777 H786
114. M. Medhora, Y. Chen, S. Gruenloh, and et al. 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol 294 5 2008 L902 L911
115. W. Yu, L. Chen, Y.Q. Yang, and et al. Cytochrome P450 omega-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer Cancer Chemother Pharmacol 68 3 2011 619 629
116. W. Yu, H. Chai, Y. Li, and et al. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer Toxicol Appl Pharmacol 264 1 2012 73 83
117. A. Alexanian, and A. Sorokin Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential Onco Targets Ther 6 2013 243 255